Ministry
of Health and Family Welfare
There is no shortage of oxygen
supply at the national level, states need to monitor oxygen inventory mechanism
of hospitals so that timely replenishment takes place: Health Secretary
There are a few cases where reactions can occur in plasma therapy and that is
why we will take a considered view of the recent study: DG, ICMR
Russian vaccine has not yet completed Phase 3 trial, in talks for conducting
Phase 3 trial in India: DG, ICMR
Posted
On: 15 SEP 2020 7:03PM by PIB Mumbai
:
In this week, more than 38.59 lakh patients have recovered
from COVID-19 in
Presently, there are only 4 states, that is,
Stating these, the Health Secretary presented a graph
showing the daily average of new cases in a week-on-week basis, starting from
first week of July, in the top 5 states, that is,
A similar graph plotting the trend of daily average deaths
in a week-on-week basis in the top five states, shows an increasing trend in
This apart,
In reply to a media query on oxygen supply for COVID-19
patients, the Health Secretary stated, while India has a capacity of
manufacturing 6,900 Metric Tonnes oxygen on a daily basis, around 2,800 metric
tonnes of oxygen are required for COVID-19 and non-COVID health use, while
around 2200 metric tonnes are used up for industrial purposes. Hence, at the
national level there is no shortage of oxygen and today morning, there was a
surplus of 1,900 metric tonnes of oxygen. Further, as per today morning's report,
roughly 6% of COVID-19 patients nationally required oxygen support. Stating
these, the Health Secretary said, the problem arises when there is no oxygen
inventory management and when there is a possible shortage of alert generation
mechanism at the hospital level which needs to be monitored by states and UTs,
so that replenishment can be done in a timely manner. He added, Health Ministry
has held detailed meetings with states, in which it has been advised to start a
control room for monitoring oxygen supply and requirements on a daily basis. A
virtual control room has also been started at the level of the Union
Government, where a Joint Secretary each from the Health Ministry and the
Department of Industries, and an officer each from PESO and DCGI are in charge.
Their contact numbers and email IDs are in public domain.
In reply to a query on the latest updates on vaccines,
DG-ICMR, Prof. (Dr.) Bhargava stated, Cadila and Bharat Biotech's Phase 2
trials are under process, while Serum Institute is about to start its Phase 3
trials at 15 sites in the country. Speaking about the vaccine developed in
Answering a media query on effectiveness of plasma therapy,
Dr. Bhargava said, randomised control trials conducted on 464 patients at 39
hospitals in 25 districts across 14 states/UTs has shown that it does not
reduce mortality or prevent progression from moderate to severe disease.
However, the DG-ICMR also clarified that these findings are under peer-review.
The National Task Force and Joint Monitoring Group of the Ministry of Health
and Family Welfare will take a decision on continuity of plasma therapy once
the full publication comes out after peer review of the findings. "There
are a few cases where reactions can occur and that is why we will take a
considered view once we get the full publication of this study", stated
DG, ICMR.
While addressing a query on sero-survey, DG, ICMR stated,
the national sero-survey, which was done in April-May and is being repeated
after three months, has been completed in 68 out of 70 districts. After
analysis of the results by this month end, the two studies can be compared. He
added that sero-survey also brings out infection fatality rate, which was found
to be between 0.5-0.6 in the last national sero-survey, which was much below
that in many other countries.
In reply to a query, Health Secretary stated, recently
a guidance note on
countering post-COVID complications has been issued.
Click here,
to access the presentation made by the Health Secretary today.
*****
DJM/SC
(Release ID: 1654663) Visitor Counter : 2
Ministry
of Health and Family Welfare
‘Pradhan Mantri Garib Kalyan
Package Insurance Scheme for Health Workers Fighting COVID-19’ extended for
another 6 months
Posted
On: 15 SEP 2020 6:33PM by PIB
The ‘Pradhan Mantri Garib Kalyan Package Insurance Scheme
for Health Workers Fighting COVID-19’ was announced on 30 March 2020 for a
period of 90 days. This was extended for a further period of 90 days i.e. up to
25th Sept,
2020.
The scheme has now been extended for another 180 days i.e. 6 months.
This Central Sector Scheme provides an
insurance cover of Rs. 50 lakh to healthcare providers, including community
health workers, who may have to be in direct contact and care of COVID-19
patients and therefore at risk of being infected. It also includes accidental
loss of life on account of contracting COVID-19.
The scheme also covers private hospital
staff/ retired/volunteer/ local urban bodies/contract/daily wage/
ad-hoc/outsourced staff requisitioned by States/ Central hospitals/autonomous
hospitals of Central/States/UTs, AIIMS & INIs/ hospitals of Central
Ministries drafted for COVID-19 related responsibilities.
The insurance provided under this scheme
is over and above any other insurance cover being availed of by the
beneficiary.
There is no age limit for this scheme and individual
enrolment is not required. The entire amount of premium for this scheme is
being borne by the Ministry of Health and Family Welfare, Government of India.
The benefit/claim under this policy is in addition to the amount payable under
any other policies. Ministry of Health and Family welfare has collaborated with
the New India Assurance (NIA) Company Limited for providing the insurance amount
based on the guidelines prepared for the scheme.
Till date, under the scheme, a total of 61 claims are
processed and paid. 156 claims are under examination by New India Assurance
(NIA) Company Limited, and in 67 cases claims forms are yet to be submitted by
the States.
PMGKP
Insurance Scheme
States/UTs: Summary of the claims as on
15/09/2020
S. No. |
State/UT |
Claims Received by NIA |
Claim processed By NIA |
Claim forms under examination At NIA |
Claims not eligible** |
Claim forms awaited From states |
1 |
Andaman &
Nicobar |
0 |
0 |
0 |
0 |
1 |
2 |
Andhra Pradesh |
20 |
4 |
12 |
4 |
4 |
3 |
Arunachal
Pradesh |
1 |
1 |
0 |
0 |
2 |
4 |
|
5 |
1+1 |
3 |
0 |
0 |
5 |
|
16 |
2 |
12 |
2 |
1 |
6 |
|
1 |
0 |
1 |
0 |
0 |
7 |
Chhattisgarh |
3 |
0 |
1 |
2 |
3 |
8 |
|
9 |
1 |
8 |
0 |
10 |
9 |
|
28 |
8+1 |
13 |
6 |
0 |
10 |
Haryana |
0 |
0 |
0 |
0 |
3 |
11 |
Himachal Pradesh |
1 |
0 |
1 |
0 |
0 |
12 |
Jammu &
Kashmir |
5 |
0 |
5 |
0 |
0 |
13 |
Jharkhand |
7 |
0 |
4 |
3 |
2 |
14 |
Karnataka |
8 |
3 |
2 |
3 |
2 |
15 |
Kerala |
3 |
3 |
0 |
0 |
0 |
16 |
Madhya Pradesh |
9 |
1 |
4 |
4 |
0 |
17 |
|
49 |
13+1 |
19 |
16 |
8 |
18 |
Mizoram |
2 |
0 |
1 |
1 |
0 |
19 |
Odisha |
42 |
0 |
42 |
0 |
5 |
20 |
Puducherry |
0 |
0 |
0 |
0 |
4 |
21 |
|
1 |
1 |
0 |
0 |
7 |
22 |
Rajasthan |
17 |
4 |
5 |
8 |
1 |
23 |
Tamil Nadu |
20 |
4+1 |
8 |
7 |
2 |
24 |
Telangana |
11 |
2 |
6 |
3 |
9 |
25 |
Uttar Pradesh |
11 |
5+1 |
2 |
3 |
1 |
26 |
|
13 |
3 |
7 |
3 |
2 |
|
Total |
282 |
61 |
156 |
65 |
67 |
The Scheme shows the commitment of the Union Government to
ensure the welfare and wellbeing of the Healthcare Workers who have been on the
forefront of the fight against the pandemic. It is due to their selfless
service and dedication to work, that India has been able to sustain its fight
against COVID and continue to sustain its low mortality rate (1.64%), which is
among the lowest globally (3.19% as on date).
******
MV
HFW/COVID PMGKY extension/15September2020/2
(Release ID: 1654635) Visitor Counter : 34
Ministry
of Health and Family Welfare
New Healthcare Scheme for Covid-19
Victims
Posted
On: 15 SEP 2020 3:04PM by PIB
There is provision made under ‘Pradhan Mantri Garib Kalyan
Package for Health Workers Fighting COVID-19. This is a Central Sector scheme.
The scheme provide an insurance cover of Rs. 50 lakh to
healthcare providers, including community health workers, who may have to be in
direct contact and care of COVID-19 patients and who may be at risk of being
impacted by this. It will also include accidental loss of life on account of
contracting COVID-19.
The scheme also covers private hospital staff/
retired/volunteer/ local urban bodies/contract/daily wage/ ad-hoc/outsourced
staff requisitioned by States/ Central hospitals/autonomous hospitals of
Central/States/UTs, AIIMS & INIs/ hospitals of Central Ministries drafted
for COVID-19 related responsibilities.
The insurance provided under this scheme would be over and
above any other insurance cover being availed of by the beneficiary.
In addition for treatment of those affected by COVID,
Government is implementing Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana
(AB-PMJAY) to provide health cover of Rs. 5 lakh per family per year for
secondary and tertiary care hospitalization to around 10.74 crore poor and
vulnerable families (approx. 50 crore Individuals) as per Socio-Economic Caste
Census (SECC) data. To effectively cover AB-PMJAY beneficiaries for testing and
treatment of COVID-19, packages for ‘Testing for COVID-19’ and ‘Treatment of
COVID-19’ have been notified.
The Minister of State (Health and Family Welfare), Sh
Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here
today.
*****
MV
(Release ID: 1654457) Visitor Counter : 122
Ministry
of Health and Family Welfare
Revised National Tuberculosis
Control Programme
Posted
On: 15 SEP 2020 3:04PM by PIB
Rapid molecular diagnostics are presently available at 1360
blocks across the country. State wise number of blocks with rapid
molecular diagnostics is given below:
State wise number of blocks with rapid
molecular diagnostics |
||
Sl.
No |
State |
No. Blocks with Rapid Molecular
Diagnostics |
1 |
Andaman & Nicobar Islands |
4 |
2 |
Andhra Pradesh |
206 |
3 |
Arunachal Pradesh |
12 |
4 |
|
33 |
5 |
|
60 |
6 |
|
3 |
7 |
Chhattisgarh |
33 |
8 |
Dadra &Nagar Haveli |
1 |
9 |
Daman & Diu |
2 |
10 |
|
27 |
11 |
|
2 |
12 |
|
58 |
13 |
Haryana |
29 |
14 |
Himachal Pradesh |
21 |
15 |
Jammu & Kashmir |
17 |
16 |
Jharkhand |
38 |
17 |
Karnataka |
68 |
18 |
Kerala |
20 |
19 |
Ladakh |
2 |
20 |
|
1 |
21 |
Madhya Pradesh |
66 |
22 |
|
119 |
23 |
Manipur |
9 |
24 |
Meghalaya |
7 |
25 |
Mizoram |
8 |
26 |
Nagaland |
9 |
27 |
Odisha |
49 |
28 |
Puducherry |
2 |
29 |
|
27 |
30 |
Rajasthan |
66 |
31 |
|
5 |
32 |
Tamil Nadu |
69 |
33 |
Telangana |
38 |
34 |
Tripura |
5 |
35 |
Uttar Pradesh |
151 |
36 |
Uttarakhand |
14 |
37 |
|
79 |
|
All
|
1360 |
62% of the TB patients were tested for Rifampcin resistance during the
period of August 2019 to 10th September 2020. The State wise details are given below:
State wise details of TB patients tested for
Rifampcin resistance |
|
State |
The total percentage of patients tested for
Rifampcin resistance since August 2019 till 10th September 2020 |
Andaman &
Nicobar Islands |
50% |
Andhra Pradesh |
77% |
Arunachal
Pradesh |
51% |
|
61% |
|
47% |
|
62% |
Chhattisgarh |
60% |
Dadra and Nagar
Haveli and Daman and |
72% |
|
53% |
|
69% |
|
66% |
Haryana |
57% |
Himachal
Pradesh |
83% |
Jammu &
Kashmir |
80% |
Jharkhand |
52% |
Karnataka |
72% |
Kerala |
62% |
Ladakh |
63% |
|
60% |
Madhya Pradesh |
59% |
|
73% |
Manipur |
58% |
Meghalaya |
67% |
Mizoram |
61% |
Nagaland |
62% |
Odisha |
83% |
Puducherry |
78% |
|
58% |
Rajasthan |
57% |
|
89% |
Tamil Nadu |
76% |
Telangana |
79% |
Tripura |
83% |
Uttar Pradesh |
54% |
Uttarakhand |
44% |
|
71% |
All |
62% |
The total number of TB cases notified from 2016 is as
under:
Year |
Total
No. of notified TB patients |
2016 |
1754957 |
2017 |
1827959 |
2018 |
2155894 |
2019 |
2404815 |
2020 (Till July 2020) |
1061003 |
The State wise details of TB cases notified is given below:
State wise details of TB cases notified
State |
2016 (Jan-Dec) |
2017 (Jan-Dec) |
2018 (Jan-Dec) |
2019 (Jan-Dec) |
|
State |
Jan - July 2020 |
Andaman and |
534 |
292 |
558 |
587 |
|
Andaman & Nicobar Islands |
297 |
Andhra Pradesh |
74373 |
83118 |
91124 |
98869 |
|
Andhra Pradesh |
37570 |
Arunachal Pradesh |
2788 |
3154 |
3419 |
2938 |
|
Arunachal Pradesh |
1566 |
|
40851 |
40174 |
42896 |
48669 |
|
|
21191 |
|
97001 |
96489 |
104930 |
122671 |
|
|
51493 |
|
3413 |
5930 |
5696 |
7026 |
|
|
2816 |
Chhattisgarh |
39484 |
41272 |
43031 |
43718 |
|
Chhattisgarh |
20077 |
Dadra and Nagar Haveli |
552 |
963 |
849 |
937 |
|
Dadra and Nagar Haveli and Daman and |
663 |
Daman and |
487 |
457 |
497 |
560 |
|
|
51465 |
|
62706 |
65893 |
93580 |
107982 |
|
|
1022 |
|
1966 |
1935 |
2492 |
2410 |
|
|
73445 |
|
126665 |
149061 |
154551 |
159158 |
|
Haryana |
38811 |
Haryana |
47545 |
40751 |
65748 |
73997 |
|
Himachal Pradesh |
8673 |
Himachal Pradesh |
14961 |
16451 |
16485 |
17446 |
|
Jammu & Kashmir |
5457 |
|
9937 |
10476 |
12895 |
11860 |
|
Jharkhand |
26025 |
Jharkhand |
39515 |
44128 |
48488 |
56632 |
|
Karnataka |
39949 |
Karnataka |
68462 |
81187 |
83094 |
91703 |
|
Kerala |
12680 |
Kerala |
47293 |
22754 |
24557 |
25617 |
|
Ladakh |
161 |
|
23 |
46 |
19 |
15 |
|
|
8 |
Madhya Pradesh |
129915 |
134333 |
160144 |
187407 |
|
Madhya Pradesh |
80779 |
|
195139 |
192458 |
209642 |
227348 |
|
|
89484 |
Manipur |
2393 |
2805 |
2927 |
2553 |
|
Manipur |
1020 |
Meghalaya |
4586 |
3961 |
4867 |
5528 |
|
Meghalaya |
2661 |
Mizoram |
2205 |
2245 |
2570 |
2944 |
|
Mizoram |
1524 |
Nagaland |
2821 |
3013 |
4269 |
4794 |
|
Nagaland |
1991 |
Odisha |
43851 |
71131 |
50303 |
53612 |
|
Odisha |
27256 |
Puducherry |
1421 |
1604 |
3489 |
4606 |
|
Puducherry |
1748 |
|
39836 |
45313 |
54401 |
58204 |
|
|
29598 |
Rajasthan |
106756 |
105953 |
160168 |
175218 |
|
Rajasthan |
83015 |
|
1539 |
1271 |
1438 |
1432 |
|
|
897 |
Tamil Nadu |
96079 |
93327 |
104917 |
110845 |
|
Tamil Nadu |
41348 |
Telangana |
45003 |
1693 |
52330 |
71655 |
|
Telangana |
38583 |
Tripura |
2374 |
39223 |
2579 |
2761 |
|
Tripura |
1281 |
Uttar Pradesh |
297746 |
311041 |
420434 |
486385 |
|
Uttar Pradesh |
205633 |
Uttarakhand |
15081 |
16760 |
22362 |
26060 |
|
Uttarakhand |
12634 |
|
89656 |
97297 |
104145 |
110668 |
|
|
48182 |
Total |
1754957 |
1827959 |
2155894 |
2404815 |
|
Total |
1061003 |
The Minister of State (Health and Family Welfare), Sh
Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here
today.
*****
MV
(Release ID: 1654458) Visitor Counter : 56
Ministry
of Health and Family Welfare
New Medical Colleges set up in last
three years
Posted
On: 15 SEP 2020 3:04PM by PIB
As per information received from Board of Governors in
supersession of Medical Council of India, during the last three years, 47
medical colleges have been recognized. List is given below:
List of medical
colleges which have been recognized by the MCI/Central Govt.during the last
three (3) years.
|
|
With
an annual intake of 100 MBBS students on or after Jan., 2017. |
|
|
With
an annual intake of 100 MBBS students on or after Feb., 2017. |
|
|
With
an annual intake of 100 MBBS students on or after Feb., 2017. |
|
Karpagam Faculty of Medical Sciences & Research, |
With
an annual intake of 150 MBBS students on or after Feb., 2017. |
|
|
With
an annual intake of 150 MBBS students or after December, 2017. |
|
Indian Institute of Medical Sciences and Research, Jalna, |
With
an annual intake of 100 MBBS students on or after Jan., 2018 |
|
|
With
an annual intake of 150 MBBS students on or after Feb., 2018 |
|
BGS Global Institute of Medical Sciences, |
With
an annual intake of 150 MBBS students on or after Jan., 2018 |
|
|
With
an annual intake of 100 MBBS students on or after Jan., 2018 |
|
|
With
an annual intake of 100 MBBS students on or after Feb., 2018 |
|
|
With
an annual intake of 150 MBBS students on or after Feb., 2018 |
|
IQ |
With
an annual intake of 150 MBBS students on or after Feb., 2018 |
|
Hi-Tech Medical College & Hospital, |
With
an annual intake of 100 MBBS students/batches on or after May, 2017 |
|
Malla Reddy Institute of Medical Sciences, |
With
an annual intake of 150 MBBS students/batches on or after 2017 |
|
Hamdard Institute of Medical Sciences & Research, |
With
an annual intake of 100 MBBS students on or after December, 2016 at Hamdard Institute of Medical Sciences & Research, |
|
|
With
an annual intake of 100 MBBS students on or after January, 2018 |
|
ICARE Institute of Medical Sciences and |
With
an annual intake of 100 MBBS students on or after February, 2017 |
|
|
With
an annual intake of 50 MBBS students on or after December, 2017 |
|
|
With
an annual intake of 100 MBBS students on or after Feb., 2018. |
|
|
With
an annual intake of 100 MBBS students on or after Feb., 2018 |
|
Malla Reddy |
With
an annual intake of 150 MBBS students on or after Feb., 2018 |
|
Shridevi Institute of Medical Sciences, Tumkur |
With
an annual intake of 150 MBBS students on or after Jan., 2018 |
|
DM Wayanad Institute of Medical Sciences, Wayanad, Kerala |
With
an annual intake of 150 MBBS students on or after Feb., 2018 |
|
The |
With
an annual intake of 150 MBBS students on or after Jan., 2019. |
|
SMBT Institute of Medical Sciences & Research Centre, Nashik, |
With
an annual intake of 150 MBBS students on or after Jan., 2019. |
|
|
With
an annual intake of 150 MBBS students on or after Jan., 2019. |
|
Mayo Institute of Medical Sciences, Barabank, U.P. |
With
an annual intake of 150 MBBS students on or after March, 2017. |
|
|
With
an annual intake of 100 MBBS students on or after Feb., 2019 |
|
|
With
an annual intake of 150 MBBS students on or after Feb., 2019. |
|
|
With
an annual intake of 100 MBBS students on or after Feb., 2018. |
|
|
With
an annual intake of 150 MBBS students on or after Feb., 2019. |
|
|
With
an annual intake of 150 MBBS students on or after Jan., 2019 |
|
|
With
an annual intake of 100 MBBS students on or after Feb., 2019 |
|
|
With
an annual intake of 100 MBBS students on or after March, 2019 |
|
Integral Institute of Medical Sciences & Research, |
With
an annual intake of 100 MBBS students on or after March, 2018 |
|
|
With
an annual intake of 100 MBBS students on or after February, 2019 |
|
Rajshree Medical Research Institute, |
With
an annual intake of 150 MBBS students on or after February, 2019 |
|
Tezpur Medical |
With
an annual intake of 100 MBBS students on or after December, 2018. |
|
P.K Das Instt. Of Medical Sciences, Palakkad, Kerala |
With
an annual intake of 150 MBBS students on or afterFebruary, 2019. |
|
|
With
an annual intake of 150 MBBS students on or after February, 2019. |
|
B.K.L.Walawalkar
Rural |
With
an annual intake of 100 MBBS students on or after Jan., 2020 |
|
Gadag Institute
of Medical Sciences, Gadag |
With
an annual intake of 150 MBBS students on or after Jan., 2020 |
|
Gulbarga
Institute of Medical Sciences, |
With
an annual intake of 150 MBBS students on or after Jan., 2020 |
|
|
With
an annual intake of 150 MBBS students on or after Dec., 2020 |
|
Manyavar Kanshi
Ram Ji Government Allopathic |
With
an annual intake of 100 MBBS students on or after Feb., 2018 |
|
|
With
an annual intake of 150 MBBS students on or after Jan. 2020. |
|
Koppal Institute
of Medical Sciences, Koppal, Karnataka |
With
an annual intake of 150 MBBS students on or after Jan. 2020. |
Funds are provided, under the Centrally Sponsored Scheme
(CSS) “Establishment of new medical college attached with district/referral
hospitals” for conversion of district hospitals to Medical Colleges. Till date,
157 districts have been approved for setting up of medical colleges across the
country with funds sharing between Central Government and State in the ratio of
90:10 for North East/Special category States and 60:40 for other States.
Also, under Pradhan Mantri Swasthya Suraksha Yojana
(PMSSY), existing
Details of the funds released for construction work and for
procurement of Medical Equipment for all the upgradation projects under PMSSY
is given below:
Details of
75 Up-gradation projects under PMSSY
S. No. |
State |
Name of GMC |
Phase |
Fund released by this Ministry for
Construction work (Rs. in Crore) |
Fund released by this Ministry for
Medical Equipment (Rs. in Crore) |
1 |
Andhra Pradesh |
1. Sri
Venkateshwara Institute of Medical Sciences, Tirupati |
I |
- |
58.31 |
2. |
III |
64.43 |
44.50 |
||
3. |
III |
66.33 |
50.26 |
||
2 |
|
1. |
III |
57.06 |
46.50 |
2. |
III |
60.84 |
46.50 |
||
3 |
|
1. |
III |
45.07 |
32 |
2. |
III |
46.26 |
32 |
||
3. |
IV |
28.44 |
25.38 |
||
4. |
IV |
36.12 |
45.30 |
||
5. |
IV |
35.07 |
51.78 |
||
6. IGIMS, |
V(B) |
11.93 |
- |
||
4 |
Chhattisgarh |
1. |
IV |
32.21 |
51.05 |
2. |
IV |
32.21 |
50.75 |
||
5 |
|
1.UCMS-GTB
hospital |
IV |
- |
- |
6 |
|
1. |
III |
103.72 |
- |
7 |
|
1. |
I |
7 |
84.57 |
2. |
III |
39.08 |
52.10 |
||
3. |
IV |
- |
42.35 |
||
4. |
IV |
47.53 |
37.28 |
||
8 |
Haryana |
1.Pandit BD
Sharma Postgraduate Institute of Medical Sciences, Rohtak |
II |
56.82 |
48.10 |
9 |
Himachal Pradesh |
1. |
II |
52.28 |
52.48 |
2. |
III |
71.22 |
2.17 |
||
10 |
Jammu & Kashmir |
1. |
I |
71.05 |
41.37 |
2. |
I |
68.70 |
41.58 |
||
11 |
Jharkhand |
1.Rajendra
Institute of Medical Sciences (RIMS), |
I |
59.20 |
35.05 |
2. |
III |
47.71 |
55.71 |
||
12 |
Karnataka |
1. |
I |
53.50 |
40.14 |
2.Vijayanagar
Institute of Medical Sciences, |
III |
40.02 |
54.98 |
||
3.Karnataka
Institute of Medical Sciences, Hubli |
III |
58.13 |
39.79 |
||
13 |
Kerala |
1. |
I |
46.89 |
45 |
2. |
III |
43.93 |
36.09 |
||
3. |
III |
53.53 |
37.21 |
||
4. SCTIMST, |
V(A) |
30.94 |
79.71 |
||
14 |
Madhya Pradesh |
1. |
III |
58.81 |
44.38 |
2. |
III |
59.71 |
46.03 |
||
3. |
III |
56.67 |
39.71 |
||
4. |
IV |
71.99 |
29.21 |
||
15 |
|
1. Grant
Medical College & Sir JJ Group of Hospitals, Mumbai |
I |
- |
92.69 |
2. |
II |
- |
120.25 |
||
3. |
III |
53.70 |
45.05 |
||
4. |
III |
53.98 |
42.64 |
||
5. |
III |
41.74 |
52.25 |
||
6. |
III |
34.81 |
67.15 |
||
16 |
Odisha |
1. |
III |
71.94 |
36 |
2. |
III |
45.72 |
46.63 |
||
3. |
IV |
14.61 |
33.85 |
||
17 |
|
1. |
II |
25.61 |
64.53 |
2. |
III |
58.22 |
34.80 |
||
18 |
Rajasthan |
1.SP Medical
College, |
III |
56.62 |
43.94 |
2. |
III |
48.01 |
53.86 |
||
3. |
III |
52.90 |
38.94 |
||
4. |
IV |
57.77 |
27.36 |
||
19 |
Tamil Nadu |
1. |
I |
84.91 |
4.29 |
2. |
II |
71.10 |
28.67 |
||
3. |
III |
65.72 |
39.01 |
||
4. |
III |
66.81 |
44.17 |
||
20 |
Telangana |
1. Nizam
Institute of Medical Sciences, |
I |
82.32 |
7.68 |
2.Rajiv Gandhi
Institute of Medical Sciences, Adilabad |
III |
62.58 |
41 |
||
3. |
III |
63.65 |
42.50 |
||
21 |
Tripura |
1. |
III |
80.65 |
12.66 |
22 |
Uttar Pradesh |
1. SGPGIMS, |
I |
45.76 |
42.53 |
2. Trauma
Centre (TC) in IMS, BHU, |
I |
64.60 |
33.08 |
||
3. |
II |
79.35 |
21.50 |
||
4. |
III |
63.20 |
38.29 |
||
5. |
III |
78.12 |
40 |
||
6. |
III |
56.12 |
44.69 |
||
7. |
III |
64.36 |
52.27 |
||
8. |
IV |
32.36 |
27.65 |
||
9. |
IV |
40.54 |
40.87 |
||
10.SSB at |
V(A) |
80.76 |
31.38 |
||
11.RIO at |
V(B) |
26.66 |
- |
||
24 |
|
1. |
I |
73.56 |
11.43 |
2.BS Medical
College, Bankura |
III |
66.98 |
45 |
||
3. |
III |
43.08 |
54.95 |
||
4. |
III |
52.47 |
50 |
The Minister of State (Health and Family Welfare), Sh
Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here
today.
*****
MV
(Release ID: 1654459) Visitor Counter : 53
Ministry
of Health and Family Welfare
Increase in Mental Health issues
during the Pandemic
Posted
On: 15 SEP 2020 3:03PM by PIB
Realizing the impact that COVID-19 may have on the mental
health of the people, including children, the Government has taken a number of
initiatives to provide psychosocial support during COVID-19. These initiatives
include:
i.
Setting up of a 24/7 helpline to provide
psychosocial support, by mental health professionals, to the entire affected
population, divided into different target groups viz children, adult, elderly,
women and healthcare workers.
ii.
Issuance of guidelines/ advisories on
management of mental health issues, catering to different segments of the
society.
iii.
Advocacy through various media platforms in
the form of creative and audio-visual materials on managing stress and anxiety,
and promoting an environment of support and care for all.
iv.
Issuance of detailed guidelines by the
National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru-
"Mental Health in the times of COVID-19 Pandemic - Guidance for General
Medical and Specialized Mental Health Care Settings".
v.
All the guidelines, advisories and advocacy
material can be accessed on Ministry of Health and Family Welfare website under
“Behavioural Health – Psychosocial helpline” (https://www.mohfw.gov.in/)
vi.
Online capacity building of health workers by
NIMHANS in providing psychosocial support and training through (iGOT)-Diksha
platform.
Lack of sufficient mental health
professionals is one of the challenges faced in the mental healthcare service
delivery. The year-wise, State-wise details of mental health practitioners
however is not maintained centrally.
With a view to augment the availability of
qualified manpower in field of mental health, the Government, under NMHP, is implementing manpower development
schemes for establishment of Centres of Excellence and strengthening/
establishment of Post Graduate (PG) Departments in mental health specialties.
Till date, support has been provided for establishment of 25 Centres of
Excellence and strengthening/ establishment of 47 Post Graduate (PG)
Departments in mental health specialties in the country.
The Government is also augmenting the availability of
manpower to deliver mental healthcare services in the underserved areas of the
country by providing online training courses to various categories of
general healthcare medical and para medical professionals through the Digital
Academies established at the three Central Mental Health Institutes namely
National Institute of Mental Health and Neuro Sciences, Bengaluru, Lokopriya
Gopinath Bordoloi Regional Institute of Mental Health, Tezpur, Assam, and
Central Institute of Psychiatry, Ranchi.
The Minister of State (Health and Family Welfare), Sh
Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here
today.
*****
MV
(Release ID: 1654456) Visitor Counter : 35
Ministry
of Health and Family Welfare
COVID-19 Fatalities amongst
Healthcare Workers
Posted
On: 15 SEP 2020 3:01PM by PIB
Health is a State subject. Such data is not maintained at
Central level by Ministry of Health and Family Welfare. However, database of
those seeking relief under the “Pradhan Mantri Garib Kalyan Insurance Package”
is maintained at national level.
Ministry of Health and Family Welfare provided guideline on
Infection Prevention and Control practices to the State Governments. Training
was conducted for all the States in the month of March 2020. A training plan
was also conveyed to States to complete training up to district level by 20th March 2020.
Training on Infection Prevention and Control was also made
available for all category of healthcare workers on the iGoT platform.
States were asked to constitute Infection Prevention and
Control committees. Hospitals were also to identify a nodal officer who will
monitor the healthcare workers and review their exposure status. High risk
exposures are placed under quarantine for 7 days. Based on their
exposure/clinical profile such doctors, nursing officers and other health
workers, a decision shall be taken by the Nodal Officer/Head of the Department
(or his appointed Sub-committee) for further period of one week. An advisory
for managing health care workers working in COVID and Non-COVID areas of the
hospital was issued by Ministry of Health and Family Welfare on 18th June, 2020.
Guidelines on rational use of PPEs for hospital and
community settings (including front line workers) were issued on 24.03.2020.
These guidelines followed a risk based approach and recommended type of PPE
that needs to be used in high and low risk areas.
The healthcare workers were provided with
hydroxychloroquine for prophylaxis and prevention of infection.
N-95 masks and triple / double ply masks were brought under
price control.
Export of PPEs, N 95 masks, triple/ double ply medical
masks, goggles and visors were banned till such time we were self-reliant.
The package of Rs 15000 crores (USD 2 Billion) under “India
COVID-19 Emergency Response and Health System Preparedness Package” was been
approved by the Cabinet on 22nd April, 2020. The funds and commodities are allocated to the
states under various components including Emergency COVID-19 response.
The States were supported with 9.81 Crore tablets of Hydroxychloroquine and
28,476 ventilators supplied to States/UTs.
Initial part of the Pandemic, there were concerns on
non-availability of protective gears. However, with Government of India
stepping in to enhance capacity and allocating PPE to States as per need, this
concern was addressed. States/UTs were provided with 3.05 crore N-95 masks and
1.2 Crore PPE kits.
State-wise details of number of health care workers for
whom the relief has been sought under “Pradhan Mantri Garib Kalyan Package” is
given below:
No. of Health workers died due to
COVID-19 as per PMGKP: Insurance Scheme |
||||||
State/UT wise List (As on 11-09-2020) |
||||||
S. No. |
State/UT |
Doctors |
ANM/MPHW |
ASHA |
Others |
Total |
1 |
Andaman &
Nicobar |
1 |
0 |
0 |
0 |
1 |
2 |
Andhra Pradesh |
5 |
5 |
1 |
1 |
12 |
3 |
Arunachal
Pradesh |
0 |
0 |
0 |
0 |
0 |
4 |
|
1 |
0 |
0 |
4 |
5 |
5 |
|
4 |
1 |
1 |
0 |
6 |
6 |
|
0 |
0 |
0 |
0 |
0 |
7 |
Chhattisgarh |
2 |
0 |
1 |
1 |
4 |
8 |
|
3 |
0 |
0 |
5 |
8 |
9 |
|
5 |
6 |
2 |
1 |
14 |
10 |
Haryana |
2 |
0 |
0 |
0 |
2 |
11 |
Himachal
Pradesh |
0 |
0 |
1 |
0 |
1 |
12 |
Jammu &
Kashmir |
2 |
0 |
0 |
1 |
3 |
13 |
Jharkhand |
2 |
2 |
1 |
1 |
6 |
14 |
Karnataka |
2 |
0 |
1 |
1 |
4 |
15 |
Kerala |
0 |
0 |
0 |
1 |
1 |
16 |
Madhya Pradesh |
3 |
0 |
0 |
4 |
7 |
17 |
|
6 |
3 |
0 |
12 |
21 |
18 |
Mizoram |
0 |
0 |
0 |
2 |
2 |
19 |
Odisha |
3 |
1 |
0 |
1 |
5 |
20 |
|
1 |
2 |
1 |
1 |
5 |
21 |
Puducherry |
0 |
0 |
0 |
0 |
0 |
22 |
Rajasthan |
2 |
5 |
0 |
1 |
8 |
23 |
Tamil Nadu |
5 |
3 |
0 |
2 |
10 |
24 |
Telangana |
3 |
0 |
3 |
1 |
7 |
25 |
Uttar Pradesh |
8 |
0 |
0 |
1 |
9 |
26 |
|
4 |
4 |
2 |
4 |
14 |
|
Total |
64 |
32 |
14 |
45 |
155 |
The Minister of State (Health and Family Welfare), Sh
Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here
today.
*****
MV
(Release ID: 1654454) Visitor Counter : 42
Ministry
of Health and Family Welfare
Covid-19 Testing Labs
Posted
On: 15 SEP 2020 3:00PM by PIB
According to the Indian Council of Medical Research, an
autonomous organisation under the Department of Health Research, the total
number of testing labs all over
Month |
Number of labs setup for COVID-19 |
March, 2020 |
152 |
April, 2020 |
247 |
May, 2020 |
275 |
June, 2020 |
367 |
July, 2020 |
298 |
The details of total number of authorized testing facilities
functioning during the months of March, April, May, June and July, 2020,
month-wise and State wise is as under:
State |
March,2020 |
April, 2020 |
May, 2020 |
June, 2020 |
July, 2020 |
ANDAMAN AND |
1 |
2 |
- |
- |
1 |
ANDHRA PRADESH |
6 |
41 |
10 |
4 |
10 |
ARUNACHAL PRADESH |
- |
1 |
1 |
2 |
6 |
|
4 |
2 |
3 |
4 |
10 |
|
5 |
1 |
14 |
22 |
6 |
|
2 |
1 |
1 |
1 |
- |
CHHATTISGARH |
2 |
1 |
2 |
2 |
7 |
DADRA AND NAGAR HAVELI |
- |
1 |
- |
- |
- |
DAMAN AND |
- |
- |
- |
- |
- |
|
13 |
8 |
18 |
11 |
10 |
|
- |
3 |
2 |
- |
- |
|
8 |
10 |
21 |
14 |
5 |
HARYANA |
5 |
9 |
5 |
4 |
4 |
HIMACHAL PRADESH |
2 |
3 |
- |
6 |
11 |
|
4 |
- |
3 |
1 |
18 |
JHARKHAND |
2 |
3 |
15 |
11 |
2 |
KARNATAKA |
10 |
18 |
37 |
16 |
16 |
KERALA |
9 |
8 |
9 |
15 |
17 |
LADAKH |
- |
- |
1 |
- |
2 |
|
- |
- |
- |
- |
3 |
MADHYA PRADESH |
7 |
7 |
22 |
33 |
17 |
|
19 |
36 |
23 |
32 |
21 |
MANIPUR |
2 |
- |
- |
2 |
4 |
MEGHALAYA |
1 |
- |
2 |
4 |
5 |
MIZORAM |
1 |
- |
- |
1 |
- |
NAGALAND |
- |
- |
3 |
9 |
2 |
ODISHA |
3 |
5 |
9 |
3 |
27 |
PUDUCHERRY |
1 |
1 |
2 |
- |
2 |
|
- |
5 |
3 |
16 |
4 |
RAJASTHAN |
7 |
9 |
6 |
7 |
8 |
|
- |
- |
2 |
- |
- |
TAMIL NADU |
13 |
33 |
26 |
19 |
30 |
TELANGANA |
13 |
8 |
5 |
9 |
5 |
TRIPURA |
- |
1 |
- |
- |
- |
UTTAR PRADESH |
6 |
14 |
8 |
100 |
27 |
UTTARAKHAND |
1 |
4 |
- |
7 |
10 |
|
5 |
12 |
22 |
12 |
8 |
Grand Total |
152 |
247 |
275 |
367 |
298 |
The Minister of State (Health and Family Welfare), Sh
Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here
today.
*****
MV
(Release ID: 1654453) Visitor Counter : 39
Ministry
of Health and Family Welfare
Early Indications of COVID 19
Pandemic Outbreak in the country
Posted
On: 15 SEP 2020 2:59PM by PIB
Ministry of Health & Family Welfare was following the
evolving situation in
Before the nationwide lockdown, a series of actions were
undertaken in a pro-active, graded and pre-emptive manner based on the evolving
scenario.
To prevent entry of disease,
Points of entry screening was initiated for travellers
coming from COVID affected countries and subsequently universal screening was
done. Prior to the lockdown on 25th March, 2020, a total of 14,154 flights with 15,24,266 passengers
have been screened at these airports. Screening was also done at 12 major and
65 minor ports and land border crossings. In addition to airports, about 16.31
lakh persons were screened at land border crossings and about 86,379 persons
were screened at 12 major, 65 minor seaports. Multi-disciplinary Central teams
were deployed for inspection of airports and hospitals attached to them to
ensure proper screening and end to end management of suspect cases detected on
screening.
The Minister of State (Health and Family Welfare), Sh
Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here
today.
*****
MV
(Release ID: 1654451) Visitor Counter : 32
Ministry
of Health and Family Welfare
Checking Overcharging by Private
Hospitals
Posted
On: 15 SEP 2020 2:58PM by PIB
Government of
The public health actions were taken in a pre-emptive,
pro-active, graded manner based on the evolving scenario. A number of travel
advisories were issued restricting inflow of international travelers, till such
time, commercial flights were suspended on 23rd March, 2020. Till then, a total
of 14,154 flights with 15,24,266 passengers have been screened at these airports.
Screening was also done at 12 major and 65 minor ports and land border
crossings. In the initial part of the pandemic, India evacuated a large number
of stranded passengers from then COVID affected countries (China, Italy, Iran,
Japan, Malaysia) and again in the un-lockdown phase, a total of 12,43,176
passengers have been brought back (as on 9th September, 2020) and followed up.
Integrated Disease Surveillance Programme (IDSP) is
conducting contact tracing through community surveillance. In the earlier part
of the pandemic, this was done for travel related cases and subsequently for
cases being reported from community as a part of containment strategy. As on
10th September 2020, a total of about 40 lakh persons have been kept under
surveillance. There are 1697 laboratories conducting COVID-19 Testing.
As on 10th September, 2020, a total of 15,290 COVID
treatment facilities with 13,14,171 dedicated isolation bed without O2 support
have been created. Also, a total of 2,31,269 oxygen supported isolation beds
and 62,694 ICU beds (including 32,241 ventilator beds). Guidelines on Clinical
management of COVID-19 have been issued and are being updated regularly.
States are being supported in terms of supply of logistics.
So far 1.39 Crore of PPE Kits, 3.42 crores N-95 masks, 10.84 crore tablets of
Hydroxychloroquine and 29,779 ventilators and 1,02,400 oxygen cylinders have been
supplied to States/UTs/ Central Government hospitals so far (as on 10th
September, 2020).
Various cadres of personnel and volunteers across sectors
and departments for COVID related works and maintenance of other essential
medical services have been worked out, trained through resources made available
on the website of MoHFW, iGOT (online platform) by DOPT
(https://igot.gov.in/igot/).
MoHFW website is being daily to provide general public with
information on current status of COVID-19 spread in
More than 30 vaccine candidates have been supported which
are in different stages of development, 3 candidates are in advanced stage of
Phase I/II/III trials and more than 4 are in advanced pre-clinical development
stage. A National Expert Group on Vaccine Administration for COVID-19 has been
constituted on 7th August, 2020, under NITI Ayog. Thirteen clinical trials of
repurposed drugs have been undertaken to build a portfolio of therapeutic
options for Covid-19 patients.
Health is a State subject. The responsibility of engaging
private hospitals in treating COVID cases is that of the State
Government. Union Health Secretary has written to all
States/UTs to engage private hospitals through mutually agreeable arrangements.
Rates under PM-JAY and CGHS packages have been advised. A large number of
States have accordingly issued instructions to that affect.
The Minister of State (Health and Family Welfare), Sh
Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here
today.
*****
MV
(Release ID: 1654449) Visitor Counter : 42
Ministry
of Health and Family Welfare
Status of Development of COVID
Vaccine in
Posted
On: 15 SEP 2020 2:58PM by PIB
While the Govt. and Industry are trying their best to make
available a safe and effective vaccine for COVID-19 at the earliest, it is
difficult to comment on the exact timelines in view of various complex pathways
involved in vaccine development.
The Government has constituted a high-level National Expert
Group on vaccine administration for COVID-19 which is chaired by Member, Niti
Aayog and co-chaired by Secretary, Ministry of Health & Family Welfare.
Other representatives are: Secretary, Ministry of External Affairs, Secretary,
Department of Biotechnology, Secretary, Department of Health Research, Director
General of Health Services, Ministry of Health & Family Welfare, Director,
All India Institute of Medical Sciences, Head ECD, Indian Council of Medical
Research, Director Jawaharlal Institute of Postgraduate Medical Education and
Research (Member NTAGI) and Representatives from States & D/o Expenditure.
The committee is addressing issues related to vaccine delivery, selection of
suitable vaccines, procurement, prioritization of groups, logistics: Cold chain
requirements, finance and National/International equity.
Central Drugs Standard Control Organisation (CDSCO) has
granted test license permission for manufacture of COVID-19 Vaccine for
preclinical test, examination and analysis to the following manufacturers in
M/s Serum Institute of
M/s Cadila Healthcare Ltd.,
M/s Bharat Biotech International Ltd.,
1.
Biological E Ltd.,
2.
M/s Reliance Life Sciences Pvt Ltd., Mumbai
3.
M/s AurbindoPharma Limited,
4.
M/s Gennova Biopharmaceuticals Limited, Pune
The Indian Council of Medical Research (ICMR), an autonomous
organisation under the Department of Health Research, has informed that the
following companies are conducting clinical trials for COVID-19 vaccines in
(i) An inactivated whole virion candidate vaccine (BBV152) for
SARS-CoV-2 has been developed by Bharat Biotech International Ltd (BBIL) using
the virus isolate (NIV-2020-770) provided by ICMR-National Institute of
Virology (NIV), Pune. Characterization of the vaccine candidate has been
undertaken at ICMR-NIV followed by safety and tolerability studies in small
animals like rats, mice and rabbits. Status of clinical trials is as follows:
Phase I clinical trials alongwith parallel
studies in large animals have been completed. The trial has revealed excellent
safety of the candidate vaccine. Immunogenicity testing is in progress.
Phase II clinical trials are ongoing.
(ii) A DNA vaccine (ZyCov-D) has been developed by Cadila Healthcare
Ltd. Pre- clincial toxicity studies were conducted in small animals: mice,
rats, rabbits and guinea pigs. The vaccine has been found to be safe and
immunogenic. Cadila has partnered with ICMR for conduct of parallel pre-clinical
studies in large animals. Status of clinical trials is as follows:
Phase I clinical trials have been completed.
The trial has revealed excellent safety of the candidate vaccine.
Immunogenicity testing is in progress.
Phase II clinical trials are ongoing.
(iii) Serum Institute of India (SII) and ICMR have partnered for
clinical development of two global vaccine candidates:
ChAdOx1-S, which is a non- replicating viral vector vaccine developed
by
ICMR and SII have also partnered for clinical development of a
glycoprotein subunit nanoparticle adjuvanted vaccine developed by Novavax from
As per details provided by Department of Biotechnology
(DBT)/Department of Science and Technology(DST), more than 30 vaccine
candidates have been supported which are in different stages of development.
The ICMR has allocated Rs.25.00 crore for various studies
and other research activities pertaining to vaccine development.
The Science and Engineering Research Board (SERB), a
statutory body under the Department of Science and Technology, has supported 03
projects under COVID-19 on vaccine research under Intensified Research in High
Priority Areas (IRHPA) The sanctioned expenditure is Rs.22,27,579/- and the
committed expenditure is Rs.3,20,78,161/-.
The Department of Biotechnology is also supporting 08
proposals by Industry and academia for candidate vaccine development and
associated research resources at a total cost of Rs. 75 crore.
The Minister of State (Health and Family Welfare), Sh
Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here
today.
*****
MV
(Release ID: 1654450) Visitor Counter : 55
Ministry
of Health and Family Welfare
Allocation of Funds to States for
Battling COVID-19
Posted
On: 15 SEP 2020 2:57PM by PIB
Public health and hospitals being a State subject, the
primary responsibility of treatment of COVID-19 patients lies with the
respective State governments. States/UTs are using their own resources for
COVID-19 management including for treatment of the patients and the details are
not maintained centrally.
Besides this, States/UTs are being provided required
technical and financial assistance under National Health Mission (NHM) for
managing the COVID-19.
Further, financial assistance to States/UTs has been given
based on the number of cases and trends of COVID-19 Pandemic. Accordingly, all
the States/ UTs are provided with necessary financial support under India
COVID-19 Emergency Response and Health System Preparedness Package. States /UTs
were given flexibility to use the resources available under NHM to prepare the
public healthcare system for COVID-19 management.
During FY 2020-21, funds of Rs 4230.78 crore have been
released to the States/ UTs as on 03.09.2020 and the State wise amount
allocated and released to each State/UT is given below:
Statement showing State-wise Central Allocation and Release under the
COVID-19 Package (Phase-I and Phase-II) |
||||||
|
|
|
|
|
(Rs. in Crore) |
|
Sl. No. |
State/UT |
Central Allocation (Phase-I) |
Central Allocation (Phase-II) |
Central Release (Phase-I) |
Central Release (Phase-II) |
|
|
|
|
|
|
|
|
A. High Focus States |
|
|
|
|
||
1 |
|
80.2 |
66.23 |
80.2 |
33.11 |
|
2 |
Chhattisgarh |
29.65 |
24.49 |
29.65 |
12.24 |
|
3 |
Jharkhand |
26.86 |
22.18 |
26.86 |
11.09 |
|
4 |
Madhya Pradesh |
131.21 |
108.36 |
131.21 |
54.18 |
|
5 |
Odisha |
46.35 |
38.28 |
46.35 |
19.14 |
|
6 |
Rajasthan |
201.72 |
166.59 |
201.72 |
83.29 |
|
7 |
Uttar Pradesh |
236.4 |
195.23 |
236.4 |
97.61 |
|
|
|
|
|
|
|
|
B. Hilly States |
|
|
|
|
|
|
8 |
Himachal Pradesh |
24.08 |
19.89 |
24.08 |
19.89 |
|
9 |
Uttarakhand |
30.11 |
24.87 |
30.11 |
24.87 |
|
|
|
|
|
|
|
|
C. Other States |
|
|
|
|
|
|
10 |
Andhra Pradesh |
141.46 |
116.82 |
141.46 |
58.41 |
|
11 |
Telangana |
181.82 |
150.15 |
181.82 |
75.07 |
|
12 |
|
4.23 |
3.49 |
4.23 |
1.75 |
|
13 |
|
85.79 |
170 |
85.79 |
85 |
|
14 |
Haryana |
75.58 |
62.42 |
75.58 |
31.21 |
|
15 |
Karnataka |
128.92 |
106.47 |
128.92 |
53.23 |
|
16 |
Kerala |
219.38 |
181.17 |
219.38 |
90.59 |
|
17 |
|
393.82 |
450 |
393.82 |
0 |
|
18 |
|
71.87 |
59.35 |
71.87 |
59.36 |
|
19 |
Tamil Nadu |
312.64 |
400 |
312.64 |
199 |
|
20 |
|
81.14 |
110 |
81.14 |
110 |
|
|
Total |
2,503.23 |
2,475.99 |
2,503.23 |
1,119.04 |
|
|
|
|
|
|
|
|
D. |
|
|
|
|||
21 |
Andaman and Nicobar Isl. |
5.38 |
4.44 |
5.38 |
4.44 |
|
22 |
|
9.39 |
7.75 |
9.39 |
0 |
|
23 |
Dadra and Nagar Haveli & Daman & Diu |
0.97 |
0.8 |
0.97 |
0.8 |
|
24 |
|
0.22 |
0.18 |
0.22 |
0 |
|
|
Total |
15.96 |
13.17 |
15.96 |
5.24 |
|
E. |
|
|
|
|||
25 |
|
255.12 |
350.00 |
255.12 |
0 |
|
26 |
Puducherry |
3.06 |
4.00 |
3.06 |
0 |
|
27 |
|
78.37 |
64.72 |
78.37 |
64.72 |
|
28 |
Ladakh (UT w/o legislature) |
20 |
16.52 |
20 |
0 |
|
|
Total |
356.55 |
435.24 |
356.55 |
64.72 |
|
F. North-Eastern High Focus States |
|
|
|
|
||
29 |
Arunachal Pradesh |
9.37 |
7.74 |
9.37 |
7.74 |
|
30 |
|
84.29 |
69.61 |
84.29 |
34.81 |
|
31 |
Manipur |
6.37 |
5.26 |
6.37 |
5.26 |
|
The Minister of State (Health and Family Welfare), Sh
Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here
today.
*****
MV
(Release ID: 1654446) Visitor Counter : 46
Ministry
of Health and Family Welfare
Strategic Approach to Combat
Covid-19
Posted
On: 15 SEP 2020 2:57PM by PIB
India would be following a scenario based approach for the
following possible scenarios, (i) Travel related case reported in India,
(ii) Local transmission of COVID-19, (iii) Large outbreaks amenable to
containment, (iv) Wide-spread community Transmission of COVID-19 disease and
(v) India becomes endemic for COVID-19.
Currently many areas are experiencing large outbreaks
amenable to containment. Hence a containment strategy is being followed by
Government of India.
Government has succeeded to a great extent in controlling
the aggressive progression of COVID-19 in the country.
Ministry of Health and Family Welfare (MoHFW), Government
of India followed a graded approach for expanding COVID-19 dedicated hospital
infrastructure. Over the past 6 months, dedicated isolation beds capacity has
been expanded 36.3 times and dedicated ICU beds above 24.6 times to what
existed in March 2020. As of now, there are enough bed available to face
any contingency. Further clinical management protocol for COVID-19 was issued
and regularly updated & widely circulated. Mainstay of treatment is
appropriate rehydration, supplemental oxygen therapy, hydroxychloroquine for
mild (but high-risk cases) and for moderate cases and management of symptoms.
MoHFW has ensured adequate availability of oxygen and hydroxychloroquine. The
case fatality rate in
The low case fatality can be attributed to constant
monitoring for fatality mitigation that includes early case detection through
surveillance, monitoring of oxygen saturation, early referral to COVID
treatment facilities and adequate case management.
The Minister of State (Health and Family Welfare), Sh
Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here
today.
*****
MV
(Release ID: 1654447) Visitor Counter : 31
Ministry
of Health and Family Welfare
Cabinet approves establishment of
new All India Institute of Medical Sciences (AIIMS) at Darbhanga,
Posted
On: 15 SEP 2020 2:25PM by PIB
The Union Cabinet chaired by the Prime Minister, Shri Narendra Modi has
approved establishment of a new All India
Institute of Medical Sciences (AIIMS) at Darbhanga,
The total cost will be Rs.1264 crore and is likely to be completed
within a period of 48 months from the date of the approval of Government of
India.
Benefits to the common man/highlights
• New AIIMS will add 100 UG (MBBS) seats
and 60 B.Sc (Nursing) seats.
• New AIIMS will have 15-20 Super
Specialty Departments.
• New AIIMS will add 750 hospital beds.
• As per data of current functional AIIMS, it
is expected that each new AIIMS will cater to around 2000 OPD patients per day
and around 1000 IPD patients per month.
• PG and DM/ M.Ch Super-specialty courses will also be started in
due course.
Details of project:
Establishment of new AIIMS involves
creation of Hospital, Teaching Block for medical & nursing courses,
residential complex and allied facilities/services, broadly on the pattern of
AIIMS,
The proposed institution shall have a hospital with
capacity of 750 beds which will include Emergency / Trauma beds, ICU beds,
AYUSH beds, Private beds and Specialty & Super Specialty beds. In addition,
there will be a
Impact:
Setting up of new AIIMS would not only
transform health education and training but also address the shortfall of
health care professionals in the region. The establishment of new AIIMS will
serve the dual purpose of providing super specialty health care to the
population while also help create a large pool of doctors and other health workers
in this region that can be available for primary and secondary level
institutions / facilities being created under National Health Mission (NHM).
Construction of new AIIMS is fully funded by the Central Government. The
Operations & Maintenance expenses on new AIIMS are also fully borne by the
Central Government.
Employment Generation:
Setting up new AIIMS in the state will
lead to employment generation for nearly 3000 persons in various faculty &
non-faculty posts. Further, indirect employment generation will take place due
to facilities and services like shopping centre, canteens, etc. coming in the
vicinity of the new AIIMS.
The construction activity involved for
creation of the physical infrastructure for the AIIMS Darbhanga is also
expected to generate substantial employment during the construction phase as
well.
This will fill the gaps in tertiary health-care infrastructure as well
as facilities for quality medical education in the State and adjoining
areas. The AIIMS would not only provide the much needed super specialty /
tertiary health care at affordable costs, to the poor and needy, it would also
make available trained medical manpower for the National Rural Health Mission /
other Health Programmes of the Ministry of Health & Family Welfare.
This institute will also create trained pool of teaching resources / faculty
which can impart quality medical education.
******
VRRK
(Release ID: 1654426) Visitor Counter : 33
Ministry of Health
and Family Welfare
India continues to post very high Recoveries
More than 79,000 discharged in the last 24 hours
India ’s
Recovery Rate crosses 78%
60% of Total Active Cases in 5 Most Affected States
Posted On: 15 SEP
2020 12:12PM by PIB
The total
recovered cases stand at 38,59,399. The gap between
Recovered cases and Active cases has crossed 28 lakh today
(28,69,338).
The total
number of active cases in the country stands at 9,90,061 as
on date.
Close
to half (48.8%) of the Active
Cases are concentrated in 3 States;
1,054 case fatalities have been reported in the past 24 hours.
Of the total deaths, nearly 69% are concentrated in
five State/UTs of Maharashtra, Tamil Nadu, Karnataka, Andhra Pradesh and
More
than 37% of deaths reported are from Maharashtra
(29,894 deaths)
#
|
Name of State / UT
|
Active cases |
Confirmed cases |
Cumulative Cured/ Discharged/Migrated Cases |
Cumulative Deaths
|
||||||
As on 15.09.2020 |
As on 15.09.2020 |
As on 14.09.2020 |
Change since yesterday |
As on 15.09.2020 |
As on 14.09.2020 |
Changes since yesterday |
As on 15.09.2020 |
As on 14.09.2020 |
Change since yesterday |
||
TOTAL CASES |
990061 |
4930236 |
4846427 |
83809 |
3859399 |
3780107 |
79292 |
80776 |
79722 |
1054 |
|
1 |
|
291630 |
1077374 |
1060308 |
17066 |
755850 |
740061 |
15789 |
29894 |
29531 |
363 |
2 |
Karnataka |
98482 |
467689 |
459445 |
8244 |
361823 |
352958 |
8865 |
7384 |
7265 |
119 |
3 |
Andhra Pradesh |
93204 |
575079 |
567123 |
7956 |
476903 |
467139 |
9764 |
4972 |
4912 |
60 |
4 |
Uttar Pradesh |
67287 |
317195 |
312036 |
5159 |
245417 |
239485 |
5932 |
4491 |
4429 |
62 |
5 |
Tamil Nadu |
46912 |
508511 |
502759 |
5752 |
453165 |
447366 |
5799 |
8434 |
8381 |
53 |
6 |
Chhattisgarh |
33645 |
67327 |
63991 |
3336 |
33109 |
31931 |
1178 |
573 |
555 |
18 |
7 |
Odisha |
32344 |
155005 |
150807 |
4198 |
122024 |
118642 |
3382 |
637 |
626 |
11 |
8 |
Kerala |
30555 |
110818 |
108278 |
2540 |
79809 |
77699 |
2110 |
454 |
439 |
15 |
9 |
Telangana |
30400 |
160571 |
158513 |
2058 |
129187 |
127007 |
2180 |
984 |
974 |
10 |
10 |
|
28641 |
221533 |
218304 |
3229 |
188122 |
184748 |
3374 |
4770 |
4744 |
26 |
11 |
|
28630 |
144166 |
141763 |
2403 |
115054 |
113133 |
1921 |
482 |
469 |
13 |
12 |
|
23693 |
205919 |
202708 |
3211 |
178223 |
175139 |
3084 |
4003 |
3945 |
58 |
13 |
Madhya Pradesh |
21228 |
90730 |
88247 |
2483 |
67711 |
65998 |
1713 |
1791 |
1762 |
29 |
14 |
|
20690 |
82113 |
79679 |
2434 |
58999 |
57536 |
1463 |
2424 |
2356 |
68 |
15 |
Haryana |
20417 |
96129 |
93641 |
2488 |
74712 |
72587 |
2125 |
1000 |
975 |
25 |
16 |
J&K (UT) |
18049 |
55325 |
54096 |
1229 |
36381 |
35737 |
644 |
895 |
878 |
17 |
17 |
Rajasthan |
16726 |
104138 |
102408 |
1730 |
86162 |
84518 |
1644 |
1250 |
1236 |
14 |
18 |
|
16469 |
114834 |
113500 |
1334 |
95138 |
93883 |
1255 |
3227 |
3210 |
17 |
19 |
Jharkhand |
14064 |
62737 |
61474 |
1263 |
48112 |
46583 |
1529 |
561 |
555 |
6 |
20 |
|
13975 |
160366 |
158285 |
2081 |
145560 |
143350 |
2210 |
831 |
822 |
9 |
21 |
Uttarakhand |
10374 |
33016 |
31973 |
1043 |
22213 |
21040 |
1173 |
429 |
414 |
15 |
22 |
Tripura |
7564 |
19696 |
19165 |
531 |
11925 |
11536 |
389 |
207 |
200 |
7 |
23 |
|
4946 |
24898 |
24592 |
306 |
19648 |
19129 |
519 |
304 |
290 |
14 |
24 |
Puducherry |
4805 |
20226 |
19833 |
393 |
15027 |
14570 |
457 |
394 |
385 |
9 |
25 |
Himachal Pradesh |
3659 |
9923 |
9555 |
368 |
6182 |
6114 |
68 |
82 |
77 |
5 |
26 |
|
2847 |
8245 |
7991 |
254 |
5300 |
5170 |
130 |
98 |
93 |
5 |
27 |
Arunachal Pradesh |
1756 |
6298 |
6121 |
177 |
4531 |
4379 |
152 |
11 |
10 |
1 |
28 |
Meghalaya |
1686 |
3864 |
3724 |
140 |
2151 |
2075 |
76 |
27 |
26 |
1 |
29 |
Manipur |
1585 |
7971 |
7875 |
96 |
6340 |
6191 |
149 |
46 |
46 |
0 |
30 |
Nagaland |
1289 |
5214 |
5083 |
131 |
3915 |
3901 |
14 |
10 |
10 |
0 |
31 |
Ladakh (UT) |
903 |
3419 |
3345 |
74 |
2475 |
2436 |
39 |
41 |
40 |
1 |
32 |
|
582 |
2119 |
2086 |
33 |
1521 |
1505 |
16 |
16 |
14 |
2 |
33 |
Mizoram |
549 |
1468 |
1428 |
40 |
919 |
830 |
89 |
0 |
0 |
0 |
34 |
D&D & D&N |
248 |
2763 |
2745 |
18 |
2513 |
2488 |
25 |
2 |
2 |
0 |
35 |
|
227 |
3557 |
3546 |
11 |
3278 |
3243 |
35 |
52 |
51 |
1 |
36 |
Lakshdweep |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
****
MV
HFW/COVID
States data/15September2020/1
(Release ID: 1654383) Visitor Counter : 104
No comments:
Post a Comment